Literature DB >> 30582286

Peptide and protein mimetics by retro and retroinverso analogs.

Jagdish Rai1.   

Abstract

Retroinverso analog of a natural polypeptide can sometimes mimic the structure and function of the natural peptide. The additional advantage of using retroinverso analog is that it is resistant to proteolysis. The retroinverso analogs have peptide sequence in reverse direction with respect to natural peptide and also have chirality of amino acid inverted from L to D. The D amino acids cannot be recognized by common proteases of the body; therefore, these peptides will not be degraded easily and have a longer-lasting effect as vaccine and inhibitor drugs. There have been many contested propositions about the geometric relationship between a peptide and its retro, inverso, or retroinverso analog. A retroinverso analog sometimes fails to adopt the structure that can mimic the function of the natural peptide. In such cases, partial retroinverso analog and other modifications can help in achieving the desired structure and function. Here, we review the theory, major experimental attempts, prediction methods, and alternative strategies related to retroinverso peptidomimetics.
© 2018 John Wiley & Sons A/S.

Keywords:  chirality relationship to biology; drug design; peptide; peptidomimetic; protease and ligands (substrate/inhibitor)

Mesh:

Substances:

Year:  2019        PMID: 30582286     DOI: 10.1111/cbdd.13472

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  9 in total

1.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05

2.  Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant Acinetobacter baumannii Infection.

Authors:  Manigandan Krishnan; Joonhyeok Choi; Ahjin Jang; Young Kyung Yoon; Yangmee Kim
Journal:  Int J Mol Sci       Date:  2021-11-20       Impact factor: 5.923

3.  Retro-protein XXA is a remarkable solubilizing fusion tag for inclusion bodies.

Authors:  Xi Xie; Pei Wu; Xiaochen Huang; WenFeng Bai; Bowen Li; Ning Shi
Journal:  Microb Cell Fact       Date:  2022-04-02       Impact factor: 5.328

4.  Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein.

Authors:  Marc Sevenich; Elena Thul; Nils-Alexander Lakomek; Thomas Klünemann; Maren Schubert; Federico Bertoglio; Joop van den Heuvel; Patrick Petzsch; Jeannine Mohrlüder; Dieter Willbold
Journal:  Biomedicines       Date:  2022-02-14

5.  Enzymatic C-to-C Protein Ligation.

Authors:  Fabian B H Rehm; Tristan J Tyler; Simon J de Veer; David J Craik; Thomas Durek
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-25       Impact factor: 16.823

Review 6.  COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.

Authors:  B Robson
Journal:  Comput Biol Med       Date:  2020-04-11       Impact factor: 4.589

Review 7.  The Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2): Biochemical and Biophysical Properties, and Its Association with Adipogenesis.

Authors:  Linjia Su; Zifang Deng; Fenfei Leng
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 8.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

9.  Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.

Authors:  B Robson
Journal:  Comput Biol Med       Date:  2020-02-26       Impact factor: 4.589

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.